Autopsy report · NCT04940416

Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

“Collaboration between partners ended, covid”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 10 months after it had already started.
• Ran for about 3 years 10 months before it stopped.
• 48 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Cirrhosis; Hepatic Encephalopathy

Interventions

Neurofit (oculometric testing)

Participants

48

Sites

1

Countries

United States

Trials that died the same way

• Low Dose Ketamine Infusion for the Treatment of Resistant Depression
  “Covid-19 disruption of team” (60% match in meaning)
• RESIST-2: 2nd-line ART for HIV-2 Infection
  “COVID-19 and Funding” (60% match in meaning)
• High Risk Outpatient Intern-led Care (HeROIC) Clinic Initiative
  “Covid-19, funding” (60% match in meaning)
• Ultrasound for Rectus Femoris Measurement
  “COVID19 continually delayed in-person research” (59% match in meaning)
• Diversion Device With Breath Control
  “COVID and no plans to move forward” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.